GT Biopharma Inc. (GTBP)
NASDAQ: GTBP
· Real-Time Price · USD
2.80
-0.02 (-0.71%)
At close: Jun 17, 2025, 12:47 PM
-0.71% (1D)
| Bid | 2.8 |
| Market Cap | 7.24M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -11.67M |
| EPS (ttm) | -5.63 |
| PE Ratio (ttm) | -0.5 |
| Forward PE | -2.78 |
| Analyst | Buy |
| Ask | 2.85 |
| Volume | 11,702 |
| Avg. Volume (20D) | 49,165 |
| Open | 2.80 |
| Previous Close | 2.82 |
| Day's Range | 2.80 - 2.91 |
| 52-Week Range | 1.72 - 4.10 |
| Beta | 1.39 |
About GTBP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GTBP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GTBP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+21.18%
GT Biopharma shares are trading higher after the c...
Unlock content with
Pro Subscription
5 months ago
+60.57%
GT Biopharma shares are trading higher. Roth MKM initiated coverage on the stock with a Buy rating and set its price target at $11.
